United States
Germany
Japan
United Kingdom
China
HRAS HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Products
HRAS (untagged)-Human v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS), transcript variant 2
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-AC |
Transient overexpression of HRAS, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
HRAS (untagged)-Human v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS), transcript variant 3
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
HRAS (untagged)-Human v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS), transcript variant 2
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
Transient overexpression of HRAS, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
HRAS mouse monoclonal antibody, clone OTI1H3 (formerly 1H3)
| Applications | WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
3' UTR clone of v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) transcript variant 3 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
3' UTR clone of v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) transcript variant 1 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
3' UTR clone of v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) transcript variant 2 for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Conjugates
Clonalities
Assay Types
QC Levels
Families
Pathways
- Acute myeloid leukemia (111)
- Axon guidance (111)
- B cell receptor signaling pathway (111)
- Bladder cancer (111)
- Chemokine signaling pathway (111)
- Chronic myeloid leukemia (111)
- Endocytosis (111)
- Endometrial cancer (111)
- ErbB signaling pathway (111)
- Fc epsilon RI signaling pathway (111)
- Focal adhesion (111)
- Gap junction (111)
- Glioma (111)
- GnRH signaling pathway (111)
- Insulin signaling pathway (111)
- Long-term depression (111)
- Long-term potentiation (111)
- MAPK signaling pathway (111)
- Melanogenesis (111)
- Melanoma (111)
- Natural killer cell mediated cytotoxicity (111)
- Neurotrophin signaling pathway (111)
- Non-small cell lung cancer (111)
- Pathways in cancer (111)
- Prostate cancer (111)
- Regulation of actin cytoskeleton (111)
- Renal cell carcinoma (111)
- T cell receptor signaling pathway (111)
- Thyroid cancer (111)
- Tight junction (111)
- VEGF signaling pathway (111)
